Pfizer's Rare Disease Programs

Bert Bruce, MBA

 At NORD's Rare Diseases and Orphan Products Breakthrough Summit, we talked with Bert Bruce,  MBA, vice president of Rare Disease Commercial Development at Pfizer, about some of the programs  his company has in development - including drugs to treat patients with Duchenne muscular dystrophy, sickle cell disease, and hemophilia B.
Printer Printing...